Pharmaceutical investment mentality is a key step in your victory

Pharmaceutical investment companies all hope that they will be successful, but the outcome is not always satisfactory. It is not difficult to discover that these failed medical investment products are mostly caused by the following types of bad mentality: the Madagascar model. The market economy is a contract economy, but some manufacturers have rushed into contract disputes when they sign contracts. For example, some manufacturers believe that large-scale dealers will “re-contract and keep promises”, have great interest in some key details, and even sign an “oral agreement”. Therefore, they cannot form effective constraints on distributors when there are problems in market operations.

Weak willow type. Resolute, decisive and decisive, is the necessary psychological conditions for manufacturers to attract investment. The process of pharmaceutical investment promotion is full of variable risks. Pharmaceutical investment promotion companies must deal with various changes in the investment promotion process in a timely manner and cannot be indecisive and blind. Once some dealers sign contracts with the manufacturers and obtain rights and interests, they think that they have entered the "substantial relationship between husband and wife," and become lazy and lax. They use various reasons to demand this. At this time, if the manufacturers like the weak, with the wind down, not decisively stop the dealer's bad behavior, will make the manufacturers deeper and deeper.

Greedy large. The best fit is not the bigger the better. Many manufacturers have the greed for seeking pride in pharmaceutical investment. They like to “pure rich” and think that the bigger the dealer, the better. It is confusing by the dealers who seem to be powerful and affluent, and do not care about their suitability, their hard work. Not hard. While some large-scale dealers often face swiftly, even shoppers bully customers, for some manufacturers, especially small and medium-sized enterprises, or unable to care about, or not mind, or even to circulate money.

Bragging type. To tell the truth, doing business with integrity is the basic requirement for investment in medicine. However, in reality, many manufacturers do not consider whether or not they can perform in order to recruit a happy girlfriend. For example, the National Television Broadcasting Network broadcasts a lot, the first large-scale free distribution of goods, zero-risk returns guarantee mechanism, huge profit discounts.

Which of the pharmaceutical investment companies that are now able to survive has never weathered the storm, but why they can persist, and you flinch. In fact, all companies that have succeeded in attracting businesses through pharmaceuticals need a steady state of mind. This is the premise and the foundation. The pharmaceutical investment ideas and measures of pharmaceutical companies need to be steady and stable, and they cannot be quick and immediate. The flexible development of the customer investment resources of pharmaceutical investment enterprises and the matching of different customers under different circumstances are powerful guarantees for the continued profitability of the company.

Pharmaceutical investment enterprises all want to have as many customer resources as possible. They have good ideas for the development of pharmaceutical investment. The mistake is that the company does not have a good grasp of the role of old and new customers in the business investment promotion process. Enterprises have certain advantages of loyalty and huge sales potential. Each pharmaceutical investment enterprise has its own fixed customers. The cooperation between these customers and enterprises ranges from three months to several years and more than ten years.

In the current pharmaceutical investment promotion media, some media have their advantages in terms of customer resources and distribution channels that are incomparable to other media, and establish cooperative relationships with these investment media. Targeted product promotion for customers who specialize in a certain channel or in a certain area will achieve a multiplier effect. The cooperation between pharmaceutical investment enterprises and customers is like a man-in-law.

What kind of customers are developed in different regions is also worthy of the company's careful research. Pharmaceutical investment promotion as a fast, low-cost way to expand product access is undoubtedly a winning tactic for many pharmaceutical investment companies; however, 95% of Chinese companies’ investment in business promotion is unsuccessful! The health industry, which is regarded as a sunrise industry, has lost more than 10 billion yuan of investment fees every year. There are nearly 10,000 outstanding products that have failed to wait for the market and they have already disappeared.